Ignacio Mahillo
Overview
Explore the profile of Ignacio Mahillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Tortosa E, Aguero-Rabes P, Ruiz-Gonzalez A, Wagner-Reguero S, Tellez R, Mahillo I, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940998
Plasma biomarkers are promising tools for the screening and diagnosis of dementia in clinical settings. We analyzed plasma levels of Alzheimer's core biomarkers, neurofilament light chain (NfL) and glial fibrillary...
2.
Gomez-Tortosa E, Aguero-Rabes P, Ruiz-Gonzalez A, Wagner S, Tellez R, Mahillo I, et al.
Aging Dis
. 2024 Nov;
PMID: 39571163
Plasma biomarkers represent promising tools for the screening and diagnosis of patients with neurodegenerative conditions. However, it is crucial to account for the effects of aging on biomarker profiles, especially...
3.
Benito J, Jimenez-Carretero D, Restrepo C, Ligos J, Valentin-Quiroga J, Mahillo I, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892124
Elite controllers (ECs) are people living with HIV (PLWH) able to control HIV replication without antiretroviral therapy and have been proposed as a model of a functional HIV cure. Much...
4.
Rallon N, Jimenez-Carretero D, Restrepo C, Ligos J, Valentin-Quiroga J, Mahillo I, et al.
J Med Virol
. 2024 May;
96(5):e29646.
PMID: 38699988
Elite controllers (ECs) are an exceptional group of people living with HIV (PLWH) that control HIV replication without therapy. Among the mechanisms involved in this ability, natural killer (NK)-cells have...
5.
Fernandez-Caballero L, Martin-Merida I, Blanco-Kelly F, Avila-Fernandez A, Carreno E, Fernandez-San Jose P, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474159
, one of the most frequently inherited retinal dystrophy (IRD)-causing genes, implies a high phenotypic variability. This study aims to analyze the mutational spectrum in one of the largest cohorts...
6.
Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome
Kallmeyer A, Pello A, Canovas E, Acena A, Gonzalez-Casaus M, Tarin N, et al.
ESC Heart Fail
. 2023 Nov;
11(1):240-250.
PMID: 37950429
Aims: Abnormalities of mineral metabolism (MM) have been related to cardiovascular disorders. There are no reports on the prognostic role of MM after an acute coronary syndrome (ACS). We aim...
7.
Lopez-Rodriguez R, Ruiz-Hornillos J, Corton M, Almoguera B, Minguez P, Perez-Tomas M, et al.
Andrology
. 2022 Nov;
11(1):24-31.
PMID: 36375449
Background: Ample evidence indicates a sex-related difference in severity of COVID-19, with less favorable outcomes observed in men. Genetic factors have been proposed as candidates to explain this difference. The...
8.
Fernandez-Prado R, Pena-Esparragoza J, Santos-Sanchez-Rey B, Pereira M, Avello A, Goma-Garces E, et al.
Nefrologia (Engl Ed)
. 2022 Sep;
41(4):426-435.
PMID: 36165111
Background And Aims: Mortality among hemodialysis patients remains high. An elevated ultrafiltration rate adjusted by weight (UFR/W) has been associated with hypotension and higher risk of death and/or cardiovascular events....
9.
Hageman S, McKay A, Ueda P, Gunn L, Jernberg T, Hagstrom E, et al.
Eur Heart J
. 2022 Feb;
43(18):1715-1727.
PMID: 35165703
Aims: The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in patients with established ASCVD can be estimated with the Secondary Manifestations of ARTerial disease (SMART) risk score, and...
10.
Soria M, Corton M, Martinez-Gonzalez B, Lobo-Vega R, Vazquez-Sirvent L, Lopez-Rodriguez R, et al.
Access Microbiol
. 2021 Oct;
3(9):000259.
PMID: 34712904
COVID-19 severity and progression are determined by several host and virological factors that may influence the final outcome of SARS-CoV-2-infected patients. The objective of this work was to determine a...